Regulatory Mechanisms Controlling Morphology and Pathogenesis in Candida Albicans

Overview

Journal Curr Opin Microbiol

Specialty Microbiology

Date 2019 May 27

PMID 31129557

Citations 28

Authors

David Kadosh

Affiliations

Soon will be listed here.

Abstract

Candida albicans, a major human fungal pathogen, can cause a wide variety of both mucosal and systemic infections, particularly in immunocompromised individuals. Multiple lines of evidence suggest a strong association between virulence and the ability of C. albicans to undergo a reversible morphological transition from yeast to filamentous cells in response to host environmental cues. Most previous studies on mechanisms important for controlling the C. albicans morphological transition have focused on signaling pathways and sequence-specific transcription factors. However, in recent years a variety of novel mechanisms have been reported, including those involving global transcriptional regulation and translational control. A large-scale functional genomics screen has also revealed new roles in filamentation for certain key biosynthesis pathways. This review article will highlight several of these exciting recent discoveries and discuss how they are relevant to the development of novel antifungal strategies. Ultimately, components of mechanisms that control C. albicans morphogenesis and pathogenicity could potentially serve as viable antifungal targets.

Citing Articles

Forward genetic screen in zebrafish identifies new fungal regulators that limit host-protective -innate immune interaction.

Blair B, Bragdon E, Dhillon G, Baker N, Stasiak L, Muthig M bioRxiv. 2025; .

PMID: 39990375 PMC: 11844468. DOI: 10.1101/2025.02.14.638315.

Unveiling the roles of in : Implications for virulence and azole resistance.

Huang M, Song D, Zhou L, Jiao Z, Yang L, Yang Y Virulence. 2024; 15(1):2405000.

PMID: 39403939 PMC: 11485852. DOI: 10.1080/21505594.2024.2405000.

MIG1, TUP1 and NRG1 mediated yeast to hyphal morphogenesis inhibition in Candida albicans by ganciclovir.

Gavandi T, Patil S, Basrani S, Yankanchi S, Chougule S, Karuppayil S Braz J Microbiol. 2024; 55(3):2047-2056.

PMID: 38789908 PMC: 11405576. DOI: 10.1007/s42770-024-01344-8.

Sequential Induction of Drug Resistance and Characterization of an Initial Drug-Sensitive Isolate.

Hachem S, Fattouh N, Chedraoui C, Finianos M, Bitar I, Khalaf R J Fungi (Basel). 2024; 10(5).

PMID: 38786702 PMC: 11122215. DOI: 10.3390/jof10050347.

Single-Molecule Fluorescent In Situ Hybridization (smFISH) for RNA Detection in the Fungal Pathogen Candida albicans.

van Otterdijk S, Motealleh M, Wang Z, Visser T, Savakis P, Tutucci E Methods Mol Biol. 2024; 2784:25-44.

PMID: 38502476 DOI: 10.1007/978-1-0716-3766-1_2.

References

Sadasivam D, Huang D . Maintenance of Tissue Pluripotency by Epigenetic Factors Acting at Multiple Levels. PLoS Genet. 2016; 12(2):e1005897. PMC: 4771708. DOI: 10.1371/journal.pgen.1005897. View

Veri A, Cowen L . Progress and prospects for targeting Hsp90 to treat fungal infections. Parasitology. 2014; 141(9):1127-37. DOI: 10.1017/S0031182013002072. View

Kumamoto C, Vinces M . Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol. 2005; 7(11):1546-54. DOI: 10.1111/j.1462-5822.2005.00616.x. View

Shapiro R, Robbins N, Cowen L . Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev. 2011; 75(2):213-67. PMC: 3122626. DOI: 10.1128/MMBR.00045-10. View

Tscherner M, Zwolanek F, Jenull S, Sedlazeck F, Petryshyn A, Frohner I . The Candida albicans Histone Acetyltransferase Hat1 Regulates Stress Resistance and Virulence via Distinct Chromatin Assembly Pathways. PLoS Pathog. 2015; 11(10):e1005218. PMC: 4608838. DOI: 10.1371/journal.ppat.1005218. View

Fazly A, Jain C, Dehner A, Issi L, Lilly E, Ali A . Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci U S A. 2013; 110(33):13594-9. PMC: 3746938. DOI: 10.1073/pnas.1305982110. View

Pickering B, Willis A . The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol. 2005; 16(1):39-47. DOI: 10.1016/j.semcdb.2004.11.006. View

Pukkila-Worley R, Holson E, Wagner F, Mylonakis E . Antifungal drug discovery through the study of invertebrate model hosts. Curr Med Chem. 2009; 16(13):1588-95. PMC: 4121729. DOI: 10.2174/092986709788186237. View

Biswas S, Van Dijck P, Datta A . Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev. 2007; 71(2):348-76. PMC: 1899878. DOI: 10.1128/MMBR.00009-06. View

10.

Dongari-Bagtzoglou A, Dwivedi P, Ioannidou E, Shaqman M, Hull D, Burleson J . Oral Candida infection and colonization in solid organ transplant recipients. Oral Microbiol Immunol. 2009; 24(3):249-54. PMC: 2699610. DOI: 10.1111/j.1399-302X.2009.00505.x. View

11.

Lu Y, Su C, Liu H . A GATA transcription factor recruits Hda1 in response to reduced Tor1 signaling to establish a hyphal chromatin state in Candida albicans. PLoS Pathog. 2012; 8(4):e1002663. PMC: 3334898. DOI: 10.1371/journal.ppat.1002663. View

12.

Mignone F, Gissi C, Liuni S, Pesole G . Untranslated regions of mRNAs. Genome Biol. 2002; 3(3):REVIEWS0004. PMC: 139023. DOI: 10.1186/gb-2002-3-3-reviews0004. View

13.

Odds F . Pathogenesis of Candida infections. J Am Acad Dermatol. 1994; 31(3 Pt 2):S2-5. DOI: 10.1016/s0190-9622(08)81257-1. View

14.

Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B . Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999; 28(5):1071-9. DOI: 10.1086/514731. View

15.

Kadosh D, Johnson A . Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol Biol Cell. 2005; 16(6):2903-12. PMC: 1142434. DOI: 10.1091/mbc.e05-01-0073. View

16.

Dupont P . Candida albicans, the opportunist. A cellular and molecular perspective. J Am Podiatr Med Assoc. 1995; 85(2):104-15. DOI: 10.7547/87507315-85-2-104. View

17.

Banerjee M, Thompson D, Lazzell A, Carlisle P, Pierce C, Monteagudo C . UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell. 2008; 19(4):1354-65. PMC: 2291399. DOI: 10.1091/mbc.e07-11-1110. View

18.

OMeara T, Veri A, Ketela T, Jiang B, Roemer T, Cowen L . Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun. 2015; 6:6741. PMC: 4382923. DOI: 10.1038/ncomms7741. View

19.

Zeidler U, Lettner T, Lassnig C, Muller M, Lajko R, Hintner H . UME6 is a crucial downstream target of other transcriptional regulators of true hyphal development in Candida albicans. FEMS Yeast Res. 2008; 9(1):126-42. DOI: 10.1111/j.1567-1364.2008.00459.x. View

20.

Leach M, Farrer R, Tan K, Miao Z, Walker L, Cuomo C . Hsf1 and Hsp90 orchestrate temperature-dependent global transcriptional remodelling and chromatin architecture in Candida albicans. Nat Commun. 2016; 7:11704. PMC: 4894976. DOI: 10.1038/ncomms11704. View